http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101463952-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
filingDate | 2007-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101463952-B1 |
titleOfInvention | Pharmaceutical preparations for delayed release of active ingredients and their use, in particular for therapeutic use |
abstract | The present invention relates to novel pharmaceutical preparations based on one or more active ingredients (AP), in particular water-soluble colloidal suspensions for delayed release of protein and peptide active ingredients, and to the uses, in particular the therapeutic uses, of these preparations .n n n This preparation is a low-viscosity, water-soluble colloidal suspension based on microparticles of water-soluble, biodegradable, amphipathic polymer PO with hydrophobic (GH) (alpha-tocopherol) and at least partially ionized hydrophobic groups (GI) , And the particles can associate spontaneously and noncovalently with AP under pH = 7.0 and isotopic conditions and have a particle size of 0.5 to 100 탆. This suspension contains a polyatomic ion (Mg 2+ ) which is opposite in polarity to the polarity of the GI group of the PO and the ratio r defined by the formula below is 0.3 to 10.n n n r = n × [ IM ] / [ GI ]n n n (Wherein,n n n - n is the valence of the polyvalent ion,n n n - [ IM ] is the molar concentration of the polyelectrolyte,n n n - [ GI ] is the molar concentration of the ionic group GI.)n n n n Pharmaceutical preparations for delayed release, colloidal suspensions |
priorityDate | 2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 711.